PR Newswire Clinical TrialsOriginal article
PB125® Enhanced Vascular Function in Older Adults and Preserved Vascular Function During Disuse in Human Clinical Study
Data ReadoutpositivePB125Positive
AI Analysis
Summary
Pathways Bioscience announced positive clinical trial results for PB125, demonstrating enhanced vascular function in older adults and preserved vascular function during disuse in a randomized, double-blind, placebo-controlled study, with evidence of Nrf2 activation and antioxidant defense mechanisms.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
PB125 enhanced vascular function in older adults and preserved vascular function during disuse in randomized, double-blind, placebo-controlled study
Importance:6/10
Sentiment:
0.70
vascular functionNrf2 activationantioxidant defensesclinical datarandomized controlled trial
Read the original article
Published by PR Newswire Clinical Trials on September 25, 2026 4:30 PM